Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Improving the environment and cell interactions is key for creating human hair in the lab.

Using a collagen sponge scaffold helps stem cells become more like skin cells.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

CD2 might be a new treatment target for patchy alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Pharmacists play a crucial role in patient education and personalized care.

N1-acetylspermidine promotes hair follicle stem cell self-renewal.

Epidermal signaling helps regenerate fingertip tissue.

Blocking JAK-STAT signaling can lead to hair growth.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Baricitinib is effective and safe for treating severe alopecia areata.

JAK inhibitors show promise for treating skin diseases effectively and safely.

The document concludes that scalp conditions have various causes and can present in many different ways.